Trial intelligence / Profile preview

Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM)

ChiCTR1900026700Phase 4Recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Dec 2018
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Huoxiang Zhengqi in atopic dermatitis (AD) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Eczema Area and Severity Index. Started Dec 2018; status: recruiting.

02

Drugs

Huoxiang Zhengqi
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on ChiCTR1900026700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call